Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer. [electronic resource]
Producer: 20200131Description: 3022-3032 p. digitalISSN:- 1097-0215
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Class I Phosphatidylinositol 3-Kinases -- genetics
- Colorectal Neoplasms -- drug therapy
- Drug Synergism
- Flavonoids -- administration & dosage
- Flavonols
- Fluorouracil -- administration & dosage
- HCT116 Cells
- HT29 Cells
- Humans
- Mice
- Mutation
- Phosphorylation -- drug effects
- Signal Transduction -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.